Clinical trials
Completed Phase 3 Bacteremia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 4 |
| Aarhus University Hospital | 1 |
| Basilea Pharmaceutica | 1 |
| Bayer | 1 |
| BioWest Therapeutics Inc | 1 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Entasis Therapeutics | 1 |
| Miquel Pujol | 1 |
| Pfizer | 1 |
| Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bacteremia | 15 |
| Sepsis | 7 |
| Recurrence | 3 |
| Enterobacteriaceae Infections | 2 |
| Gram-Positive Bacterial Infections | 2 |
| Infections | 2 |
| Staphylococcal Infections | 2 |
| Bacterial Infections | 1 |
| Endocarditis | 1 |
| Endocarditis, Bacterial | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.